James D McIninch

This inventor holds 34 USPTO granted patents and 59 published patent applications. Top assignees: Alnylam Pharmaceuticals, Inc., Monsanto Technology LLC, Vir Biotechnology, Inc.. Active years: 2008-2026.

USPTO Granted Patents = 34 (Patent Applications = 59)

% Patents Active = 79.4

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 102(Granted Patents)

Company Filing History:

28 out of 465

Alnylam Pharmaceuticals, Inc.

patents

6 out of 7,300

Monsanto Technology LLC

patents

2 out of 8

Vir Biotechnology, Inc.

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12709751 - MANNAN BINDING LECTIN SERINE PEPTIDASE 2 (MASP2) IRNA COMPOSITIONS AND METHODS OF USE THEREOF (2026-08-18),

2. 12709748 - HUNTINGTIN (HTT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF (2026-08-18),

3. 12692494 - SERPIN FAMILY F MEMBER 2 (SERPINF2) iRNA COMPOSITIONS AND METHODS OF USE THEREOF (2026-07-28),

4. 12680099 - Complement component C3 iRNA compositions and methods of use thereof for treating or preventing complement component C3-associated diseases (2026-07-14),

5. 12655430 - HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF (2026-06-16),

6. 12565653 - ATAXIN3 (ATXN3) RNAi agent compositions and methods of use thereof (2026-03-03),

7. 12553053 - Transmembrane serine protease 2 (TMPRSS2) iRNA compositions and methods of use thereof (2026-02-17),

8. 12534731 - ALPHA-2A ADRENERGIC RECEPTOR (ADRA2A) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF (2026-01-27),

9. 12522822 - APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF (2026-01-13),

10. 12516322 - Microtubule associated protein Tau (MAPT) iRNA agent compositions and methods of use thereof (2026-01-06),

11. 12480125 - Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof (2025-11-25),

12. 12473550 - Coagulation factor V (F5) iRNA compositions and methods of use thereof (2025-11-18),

13. 12416006 - Cell death-inducing DFFA-like effector B (CIDEB) iRNA compositions and methods of use thereof (2025-09-16),

14. 12404508 - Ketohexokinase (KHK) iRNA compositions and methods of use thereof (2025-09-02),

15. 12391945 - Coronavirus IRNA compositions and methods of use thereof (2025-08-19),

Title: The Innovative Journey of James D McIninch

Introduction: James D McIninch, a talented inventor hailing from Burlington, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: James D McIninch holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights: With a career spanning over two decades, James D McIninch has worked tirelessly to bring his ideas to life, revolutionizing industries such as telecommunications, robotics, and renewable energy.

Collaborations: Throughout his career, James D McIninch has collaborated with leading research institutions, universities, and tech companies to further develop and commercialize his inventions, solidifying his reputation as a visionary inventor.

Conclusion: James D McIninch's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology, with his inventions leaving a lasting impact on society.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]